Insider sale
APOLLOMICS INC.
$28.64M
16.18M shares
What this filing means
ORBIMED ADVISORS II LTD plans to sell 16.18M shares of APOLLOMICS INC. valued at approximately $28.64M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/16/2023ACC: 0000947871-23-001088
16.18M
Shares to sell
$28.64M
Approx. market value
16.18M
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Business combination
Cash
3/29/2023
16.18MTotal acquired16.18M
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/29/2023 | Business combination Cash | 16.18M | — |
| Total | 16.18M | ||
Planned & Completed Dispositions1
Nasdaq Stock MarketPlanned
Units to sell
16.18M
Market value
$28.64M
11/16/2023
Total
Units
16.18M
Value
$28.64M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
11/16/2023 | 16.18M | $28.64M | Nasdaq Stock Market | Planned |
| Total | 16.18M | $28.64M | ||